[Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)]
Articolo
Data di Pubblicazione:
2013
Tipologia CRIS:
14.a.1 Articolo su rivista
Keywords:
Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Clinical Trials as Topic; Creatinine; Disease Progression; Humans; Polycystic Kidney, Autosomal Dominant; Risk Factors; Severity of Illness Index; Time Factors; Uremia; Glomerular Filtration Rate
Elenco autori:
Lacquaniti, Antonio
Link alla scheda completa:
Pubblicato in: